Katia Pagnano MD,PhD

Hematologist and Researcher of the Hematology Division of the Hematology and Hemotherapy Center at the University of Campinas, Campinas, SP, Brazil. (since 1996).

Professor of Medicine, Hematology, at the Pontifical Catholic University of Campinas (since 2021).

Dr Pagnano has previously worked as MD at the Faculty of Medicine-University of Campinas (UNICAMP), Campinas, SP, Brazil. (1991) She did her residency and fellowship training in Hematology, Hemotherapy and Bone Marrow Transplantation at Hospital das Clínicas at UNICAMP (1992-1995) and also undertook a split fellowship at the University of Pennsylvania (Philadelphia,USA) in Dr. Gewirtz lab (1998). 

Dr Pagnano has a PhD in Internal Medicine at UNICAMP (2002).  

Dr. Pagnano’s expertise is in treating patients with hematologic malignancies, in particular CML, myeloproliferative disorders (MPN) and AML.  She has participated in Brazilian CML, AML and MPN guidelines  and in the CML Latin America Leukemia Net (LALNET) TFR recommendations. She is a member of the CML Committee from the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) and the President of the Brazilian CML Working Group.

She has been a member of the iCMLf Advisory Board since 1991 and has previously undertook the iCMLf's iClimb for Cure in 2019 - Kilimanjaro. 

Dr Pagnano has participated in several clinical trials, focusing on the treatment of chronic myeloid leukemia, acute myeloid leukemia and lymphomas. She has published in peer-reviewed journals.